Human PD-1 agonist treatment alleviates neutrophilic asthma by reprogramming T cells. Helou DG, Quach C, Fung M, Painter JD, et al. J Allergy Clin Immunol 2022 Aug 10. pii: S0091-6749(22)01049.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Helou DG, Quach C, Fung M, Painter JD, et al. Human PD-1 agonist treatment alleviates neutrophilic asthma by reprogramming T cells. J Allergy Clin Immunol 2022 Aug 10. pii: S0091-6749(22)01049.
PMID: 35963455